Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-25-000286

Options or other derivatives

  • See Remarks acquired 40,185 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Calhoun Lesley Ann See Remarks 2025-07-16 Grant or award · Stock Option (Right to Buy) +40,185 40,185 D: show line 1 in the form
Loading xslF345X05/form4.xml…